Psychemedics Gross Margin 2010-2024 | PMD
Current and historical gross margin for Psychemedics (PMD) over the last 10 years. The current gross profit margin for Psychemedics as of December 31, 2024 is %.
| Psychemedics Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-12-31 |
$0.02B |
$0.01B |
36.84% |
| 2024-09-30 |
$0.02B |
$0.01B |
40.00% |
| 2024-06-30 |
$0.02B |
$0.01B |
38.10% |
| 2024-03-31 |
$0.02B |
$0.01B |
36.36% |
| 2023-12-31 |
$0.02B |
$0.01B |
34.78% |
| 2023-09-30 |
$0.02B |
$0.01B |
33.33% |
| 2023-06-30 |
$0.03B |
$0.01B |
32.00% |
| 2023-03-31 |
$0.03B |
$0.01B |
30.77% |
| 2022-12-31 |
$0.03B |
$0.01B |
29.63% |
| 2022-09-30 |
$0.03B |
$0.01B |
29.63% |
| 2022-06-30 |
$0.03B |
$0.01B |
33.33% |
| 2022-03-31 |
$0.03B |
$0.01B |
34.62% |
| 2021-12-31 |
$0.03B |
$0.01B |
40.00% |
| 2021-09-30 |
$0.02B |
$0.01B |
37.50% |
| 2021-06-30 |
$0.02B |
$0.01B |
31.82% |
| 2021-03-31 |
$0.02B |
$0.01B |
26.32% |
| 2020-12-31 |
$0.02B |
$0.01B |
23.81% |
| 2020-09-30 |
$0.03B |
$0.01B |
28.00% |
| 2020-06-30 |
$0.03B |
$0.01B |
33.33% |
| 2020-03-31 |
$0.04B |
$0.01B |
38.89% |
| 2019-12-31 |
$0.04B |
$0.02B |
39.47% |
| 2019-09-30 |
$0.04B |
$0.02B |
43.59% |
| 2019-06-30 |
$0.04B |
$0.02B |
45.00% |
| 2019-03-31 |
$0.04B |
$0.02B |
45.24% |
| 2018-12-31 |
$0.04B |
$0.02B |
46.51% |
| 2018-09-30 |
$0.04B |
$0.02B |
46.51% |
| 2018-06-30 |
$0.04B |
$0.02B |
47.62% |
| 2018-03-31 |
$0.04B |
$0.02B |
48.78% |
| 2017-12-31 |
$0.04B |
$0.02B |
50.00% |
| 2017-09-30 |
$0.04B |
$0.02B |
51.22% |
| 2017-06-30 |
$0.04B |
$0.02B |
53.49% |
| 2017-03-31 |
$0.04B |
$0.02B |
53.49% |
| 2016-12-31 |
$0.04B |
$0.02B |
52.50% |
| 2016-09-30 |
$0.04B |
$0.02B |
51.43% |
| 2016-06-30 |
$0.03B |
$0.01B |
46.67% |
| 2016-03-31 |
$0.03B |
$0.01B |
44.44% |
| 2015-12-31 |
$0.03B |
$0.01B |
44.44% |
| 2015-09-30 |
$0.03B |
$0.01B |
42.86% |
| 2015-06-30 |
$0.03B |
$0.01B |
44.83% |
| 2015-03-31 |
$0.03B |
$0.01B |
46.67% |
| 2014-12-31 |
$0.03B |
$0.02B |
50.00% |
| 2014-09-30 |
$0.03B |
$0.02B |
55.17% |
| 2014-06-30 |
$0.03B |
$0.02B |
57.14% |
| 2014-03-31 |
$0.03B |
$0.02B |
59.26% |
| 2013-12-31 |
$0.03B |
$0.02B |
57.69% |
| 2013-09-30 |
$0.03B |
$0.01B |
53.85% |
| 2013-06-30 |
$0.03B |
$0.01B |
56.00% |
| 2013-03-31 |
$0.03B |
$0.01B |
56.00% |
| 2012-12-31 |
$0.03B |
$0.02B |
60.00% |
| 2012-09-30 |
$0.03B |
$0.02B |
60.00% |
| 2012-06-30 |
$0.03B |
$0.02B |
60.00% |
| 2012-03-31 |
$0.02B |
$0.02B |
62.50% |
| 2011-12-31 |
$0.02B |
$0.02B |
62.50% |
| 2011-09-30 |
$0.02B |
$0.02B |
65.22% |
| 2011-06-30 |
$0.02B |
$0.01B |
63.64% |
| 2011-03-31 |
$0.02B |
$0.01B |
61.90% |
| 2010-12-31 |
$0.02B |
$0.01B |
63.16% |
| 2010-09-30 |
$0.02B |
$0.01B |
66.67% |
| 2010-06-30 |
$0.02B |
$0.01B |
66.67% |
| 2010-03-31 |
$0.02B |
$0.01B |
64.71% |
| 2009-12-31 |
$0.02B |
$0.01B |
58.82% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.020B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
